Back

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register

9 December 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Imaging in heart failure: what's new? Systolic and Diastolic Function EACVI Premium Access EuroEcho 2021

About the speaker

Photo
Doctor Maria Concetta Pastore

University of Siena, Siena (Italy)

6 More presentations in this session

Presentation thumbnail
The importance of right heart function in heart failure with preserved ejection fraction
Mr N. Tran (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Deep learning based classification of left ventricular function from two-dimensional echocardiographic images
Mr N. Gessert (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Explicit and automatic ejection fraction assessment on 2D cardiac ultrasound
Mr O. Moal (FR)
Abstract Slides Video
Presentation thumbnail
Left ventricular diastolic dysfunction, including an impaired myocardial relaxation pattern, predicts long-term cardiovascular and non-cardiovascular mortality in the community
Doctor K. Young (Rochester, US)
Abstract Slides Video
Presentation thumbnail
The association between epicardial adipose tissue and prognosis in heart failure with preserved and reduced ejection fraction.
Doctor N. Pugliese (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in heart failure: what's new?

The Event

Event poster

EuroEcho 2021

9 December - 11 December 2021
You may be interested in
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
LV diastolic function: how to deal with challenges
thumbnail
Congress Presentation
Evaluation of diastolic function and LV filling pressures: limitations of current guidelines 

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources